The global Tigecycline market size was valued at USD 1487.1 million in 2022 and is forecast to a readjusted size of USD 4498.2 million by 2029 with a CAGR of 17.1% during review period.
Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Global Tigecycline Sales Channel is wide, like Hospital Pharmacies, Retail Pharmacies. Hospital Pharmacies is the largest consumer channel. Tigecycline can be mainly divided into Generic Drug, Original Drug. In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.
This report is a detailed and comprehensive analysis for global Tigecycline market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tigecycline market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Tigecycline market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Tigecycline market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Tigecycline market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tigecycline
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tigecycline market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Original Drug
Generic Drug
Hospital Pharmacies
Retail Pharmacies
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Tigecycline has a broad spectrum of activity against multidrug-resistant bacteria, making it a valuable option in the fight against antibiotic resistance.
- Increased awareness and adoption of tigecycline in healthcare settings due to rising rates of complicated skin and soft tissue infections (cSSTIs) and intra-abdominal infections (IAIs).
Weaknesses:
- Tigecycline is associated with a higher risk of treatment failure in certain infections, limiting its clinical applicability compared to other antibiotics.
- The drug's unique formulation requires parenteral administration, which may restrict its use in outpatient settings or for patients with compliance challenges.
Opportunities:
- Expansion of clinical indications for tigecycline could increase its market share, especially in treating resistant infections in immunocompromised patients.
- Growing investment in antibiotic development and antimicrobial stewardship programs may lead to enhanced awareness and utilization of tigecycline.
Threats:
- Competition from newly developed antibiotics targeting similar pathogens may reduce tigecycline's market presence and sales.
- Regulatory challenges and potential restrictions on the use of tigecycline due to safety concerns may impact its market growth in the future.
Political:
- Increased government focus on combating antibiotic resistance may drive policies supporting the use of tigecycline in resistant infection treatments.
- National healthcare regulations and reimbursement policies may affect the accessibility and affordability of tigecycline in different regions.
Economic:
- The rising economic burden of drug-resistant infections could lead to greater demand for tigecycline, especially in high-cost healthcare systems.
- Economic constraints in low-income countries may limit the widespread adoption of tigecycline due to its cost compared to alternative antibiotics.
Social:
- Growing public and healthcare provider awareness of multidrug-resistant infections could increase demand for tigecycline as a treatment option.
- Patient preference for oral antibiotics over intravenous formulations may limit tigecycline's use, which is available only in injectable form.
Technological:
- Advances in molecular diagnostics and bacterial resistance profiling may expand the use of tigecycline by identifying infections that are most likely to benefit from it.
- Innovations in drug delivery systems could potentially improve the administration of tigecycline, making it more accessible to a broader range of patients.
Environmental:
- The environmental impact of pharmaceutical waste, including antibiotics like tigecycline, could lead to stricter regulations on its production and disposal.
- The increasing concern about environmental sustainability could spur demand for more eco-friendly production processes for tigecycline.
Legal:
- Ongoing legal challenges related to patent expirations may impact the market dynamics of tigecycline, with generics entering the market to reduce costs.
- Stringent regulatory standards for antibiotic approval and safety may pose barriers to the rapid introduction of new tigecycline formulations.
Suppliers:
- Pharmaceutical manufacturers producing tigecycline and its active ingredients, including the key players in the global antibiotic market.
- Raw material suppliers for the production of tigecycline, such as chemical compounds and packaging materials for distribution.
Inputs:
- Clinical research data supporting the efficacy and safety of tigecycline, contributing to market growth and regulatory approvals.
- Regulatory approvals from agencies like the FDA and EMA that ensure the availability and legal distribution of tigecycline in various regions.
Process:
- Production processes for synthesizing and formulating tigecycline, including quality control and compliance with Good Manufacturing Practices (GMP).
- Distribution and marketing strategies to increase healthcare provider awareness of tigecycline's benefits, especially for resistant infections.
Outputs:
- Tigecycline as a treatment option available in hospitals, clinics, and outpatient settings for patients with complicated infections.
- Reports and data on the drug's effectiveness and market performance, influencing future research and development.
Customers:
- Hospitals and healthcare providers who use tigecycline for treating multidrug-resistant infections and complicated conditions like cSSTIs and IAIs.
- Patients requiring antibiotic treatment for severe infections, particularly those who have limited options due to resistant bacteria.
Threat of New Entrants:
- High barriers to entry due to the significant research and development costs required to develop and bring antibiotics like tigecycline to market.
- Strong regulatory approval processes and the need for substantial clinical trial data reduce the likelihood of new competitors entering the market.
Bargaining Power of Suppliers:
- Limited number of suppliers for the active ingredients in tigecycline can give these suppliers considerable leverage in pricing and supply terms.
- Dependency on specialized raw materials and production processes for tigecycline gives suppliers some control over the market.
Bargaining Power of Buyers:
- Hospitals and healthcare providers may have bargaining power due to bulk purchasing agreements and alternative treatment options available in the market.
- Rising awareness of antimicrobial resistance (AMR) may lead to increased demand for effective antibiotics like tigecycline, reducing buyer power in some regions.
Threat of Substitutes:
- The development of new antibiotics and treatments for multidrug-resistant infections presents a constant threat to tigecycline's market share.
- Existing alternatives, such as colistin or other broad-spectrum antibiotics, could reduce the demand for tigecycline if they offer comparable effectiveness at a lower cost.
Industry Rivalry:
- The presence of well-established pharmaceutical companies and generic alternatives leads to high competition in the antibiotic market, including for tigecycline.
- Price competition from generics and other effective antibiotics could pressure tigecycline's market growth and profitability.
Raw Material Suppliers:
- The supply of high-quality active pharmaceutical ingredients (APIs) for tigecycline is essential for consistent product quality and effective production.
- Fluctuations in the cost of raw materials and availability from global suppliers can impact production costs and pricing strategies for tigecycline.
Manufacturers:
- Key pharmaceutical manufacturers play a critical role in the production of tigecycline, and their capacity and technological advancements influence market supply.
- The reliance on Good Manufacturing Practices (GMP) and adherence to stringent regulatory standards can affect manufacturing timelines and scalability.
Research and Development:
- Ongoing R&D in antibiotic resistance and formulation improvements will influence the continued innovation and market adoption of tigecycline.
- Investment in clinical trials and the development of combination therapies may enhance the therapeutic applications of tigecycline, expanding its market reach.
Distribution Channels:
- Distribution of tigecycline is primarily through hospitals and healthcare providers, with growing interest in reaching outpatient settings for specific patient populations.
- Supply chain management, including storage and transportation requirements for temperature-sensitive products, is critical to maintaining the drug’s efficacy and availability.
Regulatory Approvals:
- Regulatory bodies like the FDA and EMA play a significant role in approving new formulations and indications, impacting the accessibility of tigecycline in different regions.
- Compliance with national and international standards for antibiotic use, especially in combating resistant infections, is necessary to ensure continued market authorization and uptake.
End Users:
- Hospitals, healthcare providers, and clinicians are the primary end users of tigecycline, particularly in treating multi-drug resistant infections in critical care settings.
- Growing use among outpatient clinics and specialty care centers as resistance to conventional antibiotics rises, expanding the potential patient base for tigecycline.
Market Demand:
- Demand for tigecycline is driven by the increasing prevalence of multidrug-resistant infections, particularly in high-risk patient populations.
- Rising global awareness and healthcare initiatives aimed at addressing antibiotic resistance may further accelerate the demand for tigecycline in regions with high infection rates.
Chapter 1, to describe Tigecycline product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tigecycline, with price, sales, revenue and global market share of Tigecycline from 2018 to 2023.
Chapter 3, the Tigecycline competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tigecycline breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tigecycline market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tigecycline.
Chapter 14 and 15, to describe Tigecycline sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Tigecycline
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tigecycline Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Tigecycline Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.5 Global Tigecycline Market Size & Forecast
1.5.1 Global Tigecycline Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tigecycline Sales Quantity (2018-2029)
1.5.3 Global Tigecycline Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer (Wyeth)
2.1.1 Pfizer (Wyeth) Details
2.1.2 Pfizer (Wyeth) Major Business
2.1.3 Pfizer (Wyeth) Tigecycline Product and Services
2.1.4 Pfizer (Wyeth) Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer (Wyeth) Recent Developments/Updates
2.2 Sino Biopharmaceutical
2.2.1 Sino Biopharmaceutical Details
2.2.2 Sino Biopharmaceutical Major Business
2.2.3 Sino Biopharmaceutical Tigecycline Product and Services
2.2.4 Sino Biopharmaceutical Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sino Biopharmaceutical Recent Developments/Updates
2.3 Zhejiang Hisun Pharma
2.3.1 Zhejiang Hisun Pharma Details
2.3.2 Zhejiang Hisun Pharma Major Business
2.3.3 Zhejiang Hisun Pharma Tigecycline Product and Services
2.3.4 Zhejiang Hisun Pharma Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhejiang Hisun Pharma Recent Developments/Updates
2.4 Jiangsu Hansoh Pharmaceutical
2.4.1 Jiangsu Hansoh Pharmaceutical Details
2.4.2 Jiangsu Hansoh Pharmaceutical Major Business
2.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Product and Services
2.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Tigecycline Product and Services
2.5.4 Abbott Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Recent Developments/Updates
2.6 Natco Pharma
2.6.1 Natco Pharma Details
2.6.2 Natco Pharma Major Business
2.6.3 Natco Pharma Tigecycline Product and Services
2.6.4 Natco Pharma Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Natco Pharma Recent Developments/Updates
2.7 Lyka Labs Limited
2.7.1 Lyka Labs Limited Details
2.7.2 Lyka Labs Limited Major Business
2.7.3 Lyka Labs Limited Tigecycline Product and Services
2.7.4 Lyka Labs Limited Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lyka Labs Limited Recent Developments/Updates
2.8 Fresenius Kabi
2.8.1 Fresenius Kabi Details
2.8.2 Fresenius Kabi Major Business
2.8.3 Fresenius Kabi Tigecycline Product and Services
2.8.4 Fresenius Kabi Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fresenius Kabi Recent Developments/Updates
2.9 Sandoz
2.9.1 Sandoz Details
2.9.2 Sandoz Major Business
2.9.3 Sandoz Tigecycline Product and Services
2.9.4 Sandoz Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sandoz Recent Developments/Updates
2.10 APOTEX
2.10.1 APOTEX Details
2.10.2 APOTEX Major Business
2.10.3 APOTEX Tigecycline Product and Services
2.10.4 APOTEX Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 APOTEX Recent Developments/Updates
2.11 Accord Healthcare
2.11.1 Accord Healthcare Details
2.11.2 Accord Healthcare Major Business
2.11.3 Accord Healthcare Tigecycline Product and Services
2.11.4 Accord Healthcare Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Accord Healthcare Recent Developments/Updates
2.12 Amneal Pharmaceuticals
2.12.1 Amneal Pharmaceuticals Details
2.12.2 Amneal Pharmaceuticals Major Business
2.12.3 Amneal Pharmaceuticals Tigecycline Product and Services
2.12.4 Amneal Pharmaceuticals Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Amneal Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Tigecycline by Manufacturer
3.1 Global Tigecycline Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tigecycline Revenue by Manufacturer (2018-2023)
3.3 Global Tigecycline Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tigecycline by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tigecycline Manufacturer Market Share in 2022
3.4.2 Top 6 Tigecycline Manufacturer Market Share in 2022
3.5 Tigecycline Market: Overall Company Footprint Analysis
3.5.1 Tigecycline Market: Region Footprint
3.5.2 Tigecycline Market: Company Product Type Footprint
3.5.3 Tigecycline Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Tigecycline Market Size by Region
4.1.1 Global Tigecycline Sales Quantity by Region (2018-2029)
4.1.2 Global Tigecycline Consumption Value by Region (2018-2029)
4.1.3 Global Tigecycline Average Price by Region (2018-2029)
4.2 North America Tigecycline Consumption Value (2018-2029)
4.3 Europe Tigecycline Consumption Value (2018-2029)
4.4 Asia-Pacific Tigecycline Consumption Value (2018-2029)
4.5 South America Tigecycline Consumption Value (2018-2029)
4.6 Middle East and Africa Tigecycline Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Tigecycline Sales Quantity by Type (2018-2029)
5.2 Global Tigecycline Consumption Value by Type (2018-2029)
5.3 Global Tigecycline Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Tigecycline Sales Quantity by Application (2018-2029)
6.2 Global Tigecycline Consumption Value by Application (2018-2029)
6.3 Global Tigecycline Average Price by Application (2018-2029)
7 North America
7.1 North America Tigecycline Sales Quantity by Type (2018-2029)
7.2 North America Tigecycline Sales Quantity by Application (2018-2029)
7.3 North America Tigecycline Market Size by Country
7.3.1 North America Tigecycline Sales Quantity by Country (2018-2029)
7.3.2 North America Tigecycline Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Tigecycline Sales Quantity by Type (2018-2029)
8.2 Europe Tigecycline Sales Quantity by Application (2018-2029)
8.3 Europe Tigecycline Market Size by Country
8.3.1 Europe Tigecycline Sales Quantity by Country (2018-2029)
8.3.2 Europe Tigecycline Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Tigecycline Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tigecycline Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tigecycline Market Size by Region
9.3.1 Asia-Pacific Tigecycline Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tigecycline Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Tigecycline Sales Quantity by Type (2018-2029)
10.2 South America Tigecycline Sales Quantity by Application (2018-2029)
10.3 South America Tigecycline Market Size by Country
10.3.1 South America Tigecycline Sales Quantity by Country (2018-2029)
10.3.2 South America Tigecycline Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Tigecycline Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tigecycline Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tigecycline Market Size by Country
11.3.1 Middle East & Africa Tigecycline Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tigecycline Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Tigecycline Market Drivers
12.2 Tigecycline Market Restraints
12.3 Tigecycline Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Tigecycline and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tigecycline
13.3 Tigecycline Production Process
13.4 Tigecycline Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tigecycline Typical Distributors
14.3 Tigecycline Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Tigecycline Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tigecycline Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer (Wyeth) Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer (Wyeth) Major Business
Table 5. Pfizer (Wyeth) Tigecycline Product and Services
Table 6. Pfizer (Wyeth) Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer (Wyeth) Recent Developments/Updates
Table 8. Sino Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Sino Biopharmaceutical Major Business
Table 10. Sino Biopharmaceutical Tigecycline Product and Services
Table 11. Sino Biopharmaceutical Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sino Biopharmaceutical Recent Developments/Updates
Table 13. Zhejiang Hisun Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Zhejiang Hisun Pharma Major Business
Table 15. Zhejiang Hisun Pharma Tigecycline Product and Services
Table 16. Zhejiang Hisun Pharma Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Zhejiang Hisun Pharma Recent Developments/Updates
Table 18. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Jiangsu Hansoh Pharmaceutical Major Business
Table 20. Jiangsu Hansoh Pharmaceutical Tigecycline Product and Services
Table 21. Jiangsu Hansoh Pharmaceutical Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Tigecycline Product and Services
Table 26. Abbott Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abbott Recent Developments/Updates
Table 28. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Natco Pharma Major Business
Table 30. Natco Pharma Tigecycline Product and Services
Table 31. Natco Pharma Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Natco Pharma Recent Developments/Updates
Table 33. Lyka Labs Limited Basic Information, Manufacturing Base and Competitors
Table 34. Lyka Labs Limited Major Business
Table 35. Lyka Labs Limited Tigecycline Product and Services
Table 36. Lyka Labs Limited Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lyka Labs Limited Recent Developments/Updates
Table 38. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 39. Fresenius Kabi Major Business
Table 40. Fresenius Kabi Tigecycline Product and Services
Table 41. Fresenius Kabi Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Fresenius Kabi Recent Developments/Updates
Table 43. Sandoz Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz Major Business
Table 45. Sandoz Tigecycline Product and Services
Table 46. Sandoz Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sandoz Recent Developments/Updates
Table 48. APOTEX Basic Information, Manufacturing Base and Competitors
Table 49. APOTEX Major Business
Table 50. APOTEX Tigecycline Product and Services
Table 51. APOTEX Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. APOTEX Recent Developments/Updates
Table 53. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 54. Accord Healthcare Major Business
Table 55. Accord Healthcare Tigecycline Product and Services
Table 56. Accord Healthcare Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Accord Healthcare Recent Developments/Updates
Table 58. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Amneal Pharmaceuticals Major Business
Table 60. Amneal Pharmaceuticals Tigecycline Product and Services
Table 61. Amneal Pharmaceuticals Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Amneal Pharmaceuticals Recent Developments/Updates
Table 63. Global Tigecycline Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Tigecycline Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Tigecycline Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 66. Market Position of Manufacturers in Tigecycline, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Tigecycline Production Site of Key Manufacturer
Table 68. Tigecycline Market: Company Product Type Footprint
Table 69. Tigecycline Market: Company Product Application Footprint
Table 70. Tigecycline New Market Entrants and Barriers to Market Entry
Table 71. Tigecycline Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Tigecycline Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Tigecycline Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Tigecycline Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Tigecycline Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Tigecycline Average Price by Region (2018-2023) & (USD/Unit)
Table 77. Global Tigecycline Average Price by Region (2024-2029) & (USD/Unit)
Table 78. Global Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Tigecycline Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Tigecycline Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Tigecycline Average Price by Type (2018-2023) & (USD/Unit)
Table 83. Global Tigecycline Average Price by Type (2024-2029) & (USD/Unit)
Table 84. Global Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Tigecycline Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Tigecycline Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Tigecycline Average Price by Application (2018-2023) & (USD/Unit)
Table 89. Global Tigecycline Average Price by Application (2024-2029) & (USD/Unit)
Table 90. North America Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Tigecycline Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Tigecycline Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Tigecycline Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Tigecycline Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Tigecycline Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Tigecycline Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Tigecycline Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Tigecycline Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Tigecycline Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Tigecycline Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Tigecycline Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Tigecycline Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Tigecycline Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Tigecycline Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Tigecycline Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Tigecycline Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Tigecycline Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Tigecycline Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Tigecycline Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Tigecycline Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Tigecycline Raw Material
Table 131. Key Manufacturers of Tigecycline Raw Materials
Table 132. Tigecycline Typical Distributors
Table 133. Tigecycline Typical Customers
List of Figures
Figure 1. Tigecycline Picture
Figure 2. Global Tigecycline Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tigecycline Consumption Value Market Share by Type in 2022
Figure 4. Original Drug Examples
Figure 5. Generic Drug Examples
Figure 6. Global Tigecycline Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Tigecycline Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Global Tigecycline Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Tigecycline Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Tigecycline Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Tigecycline Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Tigecycline Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Tigecycline Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Tigecycline by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Tigecycline Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Tigecycline Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Tigecycline Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Tigecycline Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Tigecycline Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Tigecycline Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Tigecycline Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Tigecycline Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Tigecycline Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Tigecycline Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Tigecycline Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Tigecycline Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Tigecycline Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Tigecycline Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Tigecycline Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Tigecycline Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Tigecycline Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Tigecycline Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Tigecycline Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Tigecycline Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Tigecycline Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Tigecycline Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Tigecycline Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Tigecycline Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Tigecycline Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Tigecycline Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Tigecycline Consumption Value Market Share by Region (2018-2029)
Figure 52. China Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Tigecycline Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Tigecycline Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Tigecycline Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Tigecycline Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Tigecycline Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Tigecycline Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Tigecycline Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Tigecycline Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Tigecycline Market Drivers
Figure 73. Tigecycline Market Restraints
Figure 74. Tigecycline Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Tigecycline in 2022
Figure 77. Manufacturing Process Analysis of Tigecycline
Figure 78. Tigecycline Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
